Clinical Trials Browser

Phase 2 × itepekimab × Lymphoid × Clear all

NCT03738423 2022-06-10

Efficacy, Safety, and Pharmacokinetic Profiles of REGN3500 Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis

Phase 2 Terminated

129 enrolled 36 charts

Dermatitis, Atopic, Lymphoma, Follicular

NCT03736967 2021-11-01

Efficacy and Safety of REGN3500 Monotherapy and Combination of REGN3500 Plus Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis

Phase 2 Terminated

206 enrolled 34 charts

Dermatitis, Atopic, Lymphoma, Follicular